CHRNA3 and cancer: CHRNA3 was identified to increase the sensitivity of cancer cells to chemotherapeutic agents, such as chelerythrine, XK-469, and dexamethasone decad, while GABRD weakened the sensitivity of pimozide and rapamycin.